WO2016178490A3 - Pharmaceutical composition for preventing or treating gout and food composition for alleviating hyperuricemia, containing extract of salvia plebeia r. br. or fraction thereof - Google Patents

Pharmaceutical composition for preventing or treating gout and food composition for alleviating hyperuricemia, containing extract of salvia plebeia r. br. or fraction thereof Download PDF

Info

Publication number
WO2016178490A3
WO2016178490A3 PCT/KR2016/004496 KR2016004496W WO2016178490A3 WO 2016178490 A3 WO2016178490 A3 WO 2016178490A3 KR 2016004496 W KR2016004496 W KR 2016004496W WO 2016178490 A3 WO2016178490 A3 WO 2016178490A3
Authority
WO
WIPO (PCT)
Prior art keywords
hyperuricemia
alleviating
fraction
pharmaceutical composition
preventing
Prior art date
Application number
PCT/KR2016/004496
Other languages
French (fr)
Korean (ko)
Other versions
WO2016178490A2 (en
Inventor
오좌섭
김진규
최용문
현정미
홍성수
최춘환
서찬곤
Original Assignee
재단법인 경기과학기술진흥원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 경기과학기술진흥원 filed Critical 재단법인 경기과학기술진흥원
Publication of WO2016178490A2 publication Critical patent/WO2016178490A2/en
Publication of WO2016178490A3 publication Critical patent/WO2016178490A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a pharmaceutical composition for treating gout and a food composition for alleviating hyperuricemia, the compositions containing an extract of Salvia plebeia R. Br. or a fraction thereof. The compositions exhibit xanthine oxidase inhibitory activity, thereby showing a gout prevention or treatment effect.
PCT/KR2016/004496 2015-05-04 2016-04-29 Pharmaceutical composition for preventing or treating gout and food composition for alleviating hyperuricemia, containing extract of salvia plebeia r. br. or fraction thereof WO2016178490A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0062632 2015-05-04
KR1020150062632A KR101702120B1 (en) 2015-05-04 2015-05-04 A Pharmaceutical Composition Comprising Extract or Fraction of Salvia plebeia R. Br. for Preventing or Treating Gout and a Composition for Improving Hyperuricemia Comprising the Same

Publications (2)

Publication Number Publication Date
WO2016178490A2 WO2016178490A2 (en) 2016-11-10
WO2016178490A3 true WO2016178490A3 (en) 2017-01-05

Family

ID=57218249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/004496 WO2016178490A2 (en) 2015-05-04 2016-04-29 Pharmaceutical composition for preventing or treating gout and food composition for alleviating hyperuricemia, containing extract of salvia plebeia r. br. or fraction thereof

Country Status (2)

Country Link
KR (1) KR101702120B1 (en)
WO (1) WO2016178490A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102070789B1 (en) * 2019-05-21 2020-01-29 한국 한의학 연구원 Composition for ameliorating or treating acne comprising Salvia plebeia extract and its fraction as effective component
CN113694080B (en) * 2021-08-17 2023-03-28 南京晓庄学院 Antiviral application of common sage herb polysaccharide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102861264A (en) * 2012-10-17 2013-01-09 张群 Traditional Chinese medicine for treating gout
KR20130129868A (en) * 2012-05-21 2013-11-29 한국생명공학연구원 A pharmaceutical composition comprising extract or fraction of salvia plebeia r. br. for preventing or treating stat3-mediated disease
KR101456287B1 (en) * 2014-03-26 2014-10-31 구례군 The method for manufacturing anti-oxidant and anti-inflammatory functional tea product made from salvia plebeia leaves, and the product made by the method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100527109B1 (en) 2005-05-19 2005-11-09 학교법인 인제학원 Pharmaceutical composition comprising the extract of Allium tuberosum ROTTER for the prevention and treatment of gout.
KR101168379B1 (en) 2010-06-03 2012-07-25 강원대학교산학협력단 Composition for Prevention and Treatment of Gout, Hypertension and Cancer comprising Acanthopanax senticosus Fruits Extracts
KR101332028B1 (en) 2012-06-01 2013-11-22 박말녀 The fermentation composition contained gombo-baechu and its manufacturing method
KR20140106772A (en) 2013-02-25 2014-09-04 경북대학교 산학협력단 Composition for inhibition of gout comprising extracts of chrysanthemum indicum L.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130129868A (en) * 2012-05-21 2013-11-29 한국생명공학연구원 A pharmaceutical composition comprising extract or fraction of salvia plebeia r. br. for preventing or treating stat3-mediated disease
CN102861264A (en) * 2012-10-17 2013-01-09 张群 Traditional Chinese medicine for treating gout
KR101456287B1 (en) * 2014-03-26 2014-10-31 구례군 The method for manufacturing anti-oxidant and anti-inflammatory functional tea product made from salvia plebeia leaves, and the product made by the method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHOI, J. K. ET AL.: "Salvia Plebeia Extract Inhibits the inflammatory Response in Human Rheumatoid Synovial Fibroblasts and a Murine Model of Arthritis", PHYTOMEDICINE, vol. 22, no. 3, 14 February 2015 (2015-02-14), pages 415 - 422, XP029582881 *
JUNG, H. J. ET AL.: "Anti_inflammatory, Anti-angiogenic and Anti-nociceptive Activities of an Ethanol Extract of Salvia Plebeia R. Brown", JOURNAL OF ETHNOPHARMACOLOGY, vol. 126, no. 2, 26 August 2009 (2009-08-26), pages 355 - 360, XP026718082 *

Also Published As

Publication number Publication date
WO2016178490A2 (en) 2016-11-10
KR20160130624A (en) 2016-11-14
KR101702120B1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
WO2015142001A3 (en) Compound having cardiotonic activity and pharmaceutical composition for preventing or treating heart failure, containing same
WO2016172134A3 (en) Novel compounds
WO2017001936A3 (en) Therapeutic inhibitory compounds
WO2017001926A8 (en) Therapeutic inhibitory compounds
NZ735044A (en) Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
EP3207940A4 (en) Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure
EP3102220A4 (en) Synergistic dietary supplement compositions for the prevention, treatment or control of inflammatory disorders
EP3294761A4 (en) Compositions and methods for treatment and prevention of uropathogenice. coli
EP3103802A4 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
EP3231436A4 (en) Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient
EP3818085A4 (en) Compositions and uses thereof for treating disease or condition
EP3413904A4 (en) Herbal compositions and methods for the prevention and treatment of plant or nail infections
EP3295946A4 (en) Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy
EP3777848A4 (en) Composition for prevention or treatment of stoke
EP3327001A4 (en) Novel compound having blt inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient
EP3461486A4 (en) Pharmaceutical composition for preventing or treating dementia and improving cognitive function, comprising glasswort extract
WO2016178490A3 (en) Pharmaceutical composition for preventing or treating gout and food composition for alleviating hyperuricemia, containing extract of salvia plebeia r. br. or fraction thereof
EP3162803A4 (en) New compound for inhibiting binding between dx2 protein and p14/arf protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient
EP3501524A4 (en) Use as immune enhancer or pharmaceutical composition for treatment of dementia, comprising phytosphingosine-1-phosphate or derivative thereof
WO2016178510A3 (en) Pharmaceutical composition for preventing or treating gleevec-resistant leukemia, containing, as active ingredient, ginsenoside f1 or rg3
SG11202106163RA (en) Pharmaceutical composition for prevention or treatment of cancer comprising lactobacillus sakei wikim30 as active ingredient
EP3284464A4 (en) Composition for preventing and treating pancreatitis containing naphthoquinone-based compound as active ingredient
WO2016048007A8 (en) Quorum sensing inhibitor containing d-galactose
EA033297B1 (en) Therapeutic and nutritional compositions for functional gastrointestinal disorders
EP3616704A4 (en) Pharmaceutical composition for prevention or treatment of alzheimer's disease, comprising mountain-cultivated ginseng extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16789596

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 28.03.2018)

122 Ep: pct application non-entry in european phase

Ref document number: 16789596

Country of ref document: EP

Kind code of ref document: A2